Overview

Study of the Effect of Clinical Procedures on Drug Delivery of Mylan Fentanyl Transdermal System 25 µg/hr and Duragesic® 25 µg/hr

Status:
Terminated

Trial end date:
1969-12-31

Target enrollment:

Participant gender:

Summary

The objective of this study was to investigate the effect of clinical procedures on the drug delivery of Fentanyl Transdermal Systems, 25 mcg/h manufactured for Mylan Pharmaceuticals Inc. by Mylan Technologies Inc., and Duragesic, 25 mcg/h manufactured for Janssen Pharmaceutica by ALZA Corporation.

Phase:

Phase 1

Details

Lead Sponsor:

Mylan Pharmaceuticals

Treatments:

Fentanyl